Table 4 Clinical Characteristics
|  | Oncology Institution | Total N = 95 | ||
|---|---|---|---|---|
Northern (NOI) n = 53 | Central (COI) n = 42 | |||
Median [IQR] | Median [IQR] | Median [IQR] | ||
Time since diagnosis until admission in palliative care (months) | 21 [14,48] | 17.5 [7, 42] | 21 [9, 48] | |
| Â | n (%) | n (%) | n (%) | |
Diagnosis | Cancer | 53 (100) | 42 (100) | 95 (100) |
Cancer Diagnosis | One site | 53 (100) | 42 (100) | 95 (100) |
Two or more sites | 3 (5.7) | 3 (7.1) | 6 (6.3) | |
Cancer Site | Gastrointestinal | 23 (43.4) | 11 (26.2) | 34 (35.8) |
Head and neck | 3 (5.7) | 16 (38.1) | 19 (20) | |
Breast | 6 (11.3) | 5 (11.9) | 11 (11.6) | |
Lungs | 4 (7.5) | 4 (9.5) | 8 (8.4) | |
Gynaecological | 7 (13.2) | 1 (2.4) | 8 (8.4) | |
Prostate | 2 (3.8) | 3 (7.1) | 5 (5.3) | |
Colorectal | 3 (5.7) | 1 (2.4) | 4 (4.2) | |
Skin | 2 (3.8) | 1 (2.4) | 3 (3.2) | |
Bones | 2 (3.8) | 0 | 2 (2.1) | |
Urinary tract | 1 (1.9) | 1 (2.4) | 2 (2.1) | |
Thyroid | 1 (1.9) | 0 | 1 (1.1) | |
Others | 2 (3.8) | 2 (4.8) | 4 (4.2) | |
Treatments/Procedures | Yes | 47 (88.7) | 33 (78.6) | 80 (84.2) |
No | 6 (11.3) | 9 (21.4) | 15 (15.8) | |
Treatment/Procedure Type | Chemotherapy | 33 (62.3) | 19 (45.2) | 52 (54.7) |
Radiotherapy | 18 (34) | 22 (52.4) | 40 (42.1) | |
Hormonotherapy | 1 (1.9) | 1 (2.4) | 2 (2.1) | |
Immunotherapy | 0 | 3 (7.1) | 3 (3.2) | |
Surgery | 27 (50.9) | 13 (31.0) | 40 (42.1) | |
Tracheostomy | 1 (1.9) | 4 (9.5) | 5 (5.3) | |
Others | 1 (1.9) | 3 (7.1) | 4 (4.2) | |